Riskpilot← Back to searchSign inGet full accessINNLANDET LEGESENTER AS
ASActiveOrg 926848003Vangsvegen 31, 2317 HamarGeneral medical practice activities · NACE 8621Est. 202111 employees
Revenue 2024
NOK 7,9M
-11% vs 2023
EBITDA margin
-2.7%
-127% vs 2023
Equity ratio
29.3%
Financial strength
Net profit 2024
NOK -468K
-239% vs 2023
| Revenue | NOK 7,9M | -11% |
| EBITDA | NOK -210K | -127% |
| Net profit | NOK -468K | -239% |
| Total assets | NOK 1,3M | -27% |
| Equity | NOK 391K | -54% |
| Employees | 11 | — |
Legal name
INNLANDET LEGESENTER AS
Org number
926848003
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
23. mars 2021
Share capital
NOK 30 000
Employees
11 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Drive fellesfunksjonene for de legevirksomhetene som utføres i selskapet samt det som står i naturlig forbindelse med dette.
Address
Vangsvegen 31, 2317 Hamar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 24 | 2 073 | 8 813 | 7 879 |
| Staff expenses | −0 | −397 | −3 734 | −3 957 |
| EBITDA | −10 | 697 | 772 | −210 |
| Depreciation & amort. | −0 | −47 | −327 | −329 |
| EBIT | −10 | 651 | 445 | −539 |
| Net financials | −2 | −7 | −14 | −2 |
| Profit before tax | −12 | 644 | 431 | −541 |
| Tax | −0 | 139 | 95 | −73 |
| Net profit | −12 | 505 | 336 | −468 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 18 | 1 410 | 1 815 | 1 333 |
| Equity | 18 | 523 | 859 | 391 |
| Long-term debt | 0 | 276 | 207 | 0 |
| Short-term debt | 0 | 612 | 749 | 942 |
| Total debt | 0 | 888 | 956 | 942 |
EBITDA margin
-2.7%
This company
15.8%
Market median
-117% vs market
20212024
Equity ratio
29.3%
This company
38.2%
Market median
-23% vs market
20212024
Return on equity
-119.6%
This company
18.4%
Market median
-750% vs market
20212024
Net profit margin
-5.9%
This company
8.1%
Market median
-173% vs market
20212024
Asset turnover
5.91×
This company
1.12×
Market median
+428% vs market
20212024
Debt / equity
2.41×
This company
0.62×
Market median
-289% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Endre Balazs As | Company | 20.0% | 20.0% | 2023 |
Suma Helse As | Company | 20.0% | 20.0% | 2023 |
Xu Capital As | Company | 20.0% | 20.0% | 2023 |
Medisam As | Company | 20.0% | 20.0% | 2023 |
Trangsrud Medical As | Company | 20.0% | 20.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Marshall Holding As
INNLANDET LEGESENTER AS Board members of INNLANDET LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tehua Michael Xu | Chief Executive Officer | 0 companies |
| Inge Marshall Trangsrud | Chairman | 0 companies |
| Endre Balazs | Board of Directors | 0 companies |
| Eivind Borg Lismoen | Board of Directors | 0 companies |
| Abubakar Din | Board of Directors | 0 companies |
| Håvard Strand | Board of Directors | 0 companies |
| Sam Rahmanpour | Board of Directors | 0 companies |